These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7166104)

  • 1. [Cell-mediated immunity and its HLA restriction in nasopharyngeal cancer patients].
    Lin YC
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):254-6. PubMed ID: 7166104
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of HLA of the nasopharyngeal carcinoma epithelioid cell line and lymphoblastoid cell lines].
    Cui HY
    Zhonghua Zhong Liu Za Zhi; 1982 Aug; 4(3):168-70. PubMed ID: 7173020
    [No Abstract]   [Full Text] [Related]  

  • 3. [The cytotoxic effect of lymphocytes from patients with nasopharyngeal cancer (NPC) against a NPC epitheloid cell line (author's transl)].
    Lin YC; Chao WP; Liu CR; Hu RL; Zeng Y
    Zhonghua Zhong Liu Za Zhi; 1981 Feb; 3(1):1-4. PubMed ID: 6273085
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance.
    Laytragoon-Lewin N; Porwit-MacDonald A; Mellstedt H; Lewin F
    Anticancer Res; 2000; 20(2B):1093-100. PubMed ID: 10810402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between nasopharyngeal carcinoma and HLA antigens in Greeks.
    Zervas J; Gregoriadis S; Tourlas D; Varlegidis E; Pantazopoulos P
    Panminerva Med; 1983; 25(4):255-7. PubMed ID: 6584851
    [No Abstract]   [Full Text] [Related]  

  • 6. [HLA-A, B, C, DR antigens in north Chinese with nasopharyngeal carcinoma].
    Chen R
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1988; 23(2):106-7. PubMed ID: 3153944
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytotoxicity against non-HLA antigens in a renal transplant recipient.
    Akiyama N; Ohsawa N; Degawa H; Takeda Y; Tomikawa S; Sugimoto H; Yamauchi J; Otsubo O
    Transplant Proc; 1984 Dec; 16(6):1700-3. PubMed ID: 6390885
    [No Abstract]   [Full Text] [Related]  

  • 8. [Apparent correlation between nasopharyngeal carcinoma and HLA phenotype].
    Cui HY
    Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):249-53. PubMed ID: 7166103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cell-mediated immunity tumors of the upper respiratory tract].
    Zawisza E; Kukwa A; Borowiecki B; Papenhausen P; Makowska W
    Pol Tyg Lek; 1979 Dec; 34(50):1949-51. PubMed ID: 317152
    [No Abstract]   [Full Text] [Related]  

  • 10. Target susceptibility in cell-mediated lympholysis assays correlates with major histocompatibility complex surface antigen expression.
    Suranyi MG; Bishop GA; Waugh J; Hall BM
    Transplant Proc; 1987 Apr; 19(2):2869-72. PubMed ID: 3551229
    [No Abstract]   [Full Text] [Related]  

  • 11. International symposium on nasopharyngeal carcinoma--basic research as applied to diagnosis and treatment.
    Ablashi DV; Krueger GR; Grundmann E
    Cancer Res; 1981 May; 41(5):2014-6. PubMed ID: 6260355
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ; Yao K; Yu CJ; Chen X; Lu MP; Sun H; Li BZ; Ding CN; Zhou F
    Auris Nasus Larynx; 2006 Dec; 33(4):441-6. PubMed ID: 16934422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical significance of HLA monitoring in carcinoma of the nasopharynx].
    Síbl O; Ivasková E; Roubalová K
    Cesk Otolaryngol; 1987 Jul; 36(4):217-23. PubMed ID: 3664697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cell-mediated immunity in esophageal cancer patients--effect of "109" crude extracts on the cytotoxic effect of lymphocytes from esophageal cancer patients (author's transl)].
    Peng RL; Wang DB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Sep; 2(3):201-3. PubMed ID: 6451323
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunologic study on nasopharyngeal carcinoma patients: correlation of mononuclear cell reactivity to phytohemagglutinin and clinical stage].
    Hsu MM; Lin BL
    Taiwan Yi Xue Hui Za Zhi; 1983 Sep; 82(9):972-6. PubMed ID: 6581269
    [No Abstract]   [Full Text] [Related]  

  • 16. HLA and nasopharyngeal cancer.
    Simons MJ; Chan SH; Day NE; Wee GB; Shanmugaratnam K
    Prog Clin Biol Res; 1977; 16():145-8. PubMed ID: 905319
    [No Abstract]   [Full Text] [Related]  

  • 17. [Distribution pattern of histocompatibility antigens (HLA) in nasopharyngeal tumors].
    Beigel A; Peulen JF; Westphal E
    Arch Otorhinolaryngol; 1983 Apr; 237(3):285-8. PubMed ID: 6870662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thyroid neoplasms and HL-A system].
    Májský A; Feix C; Nĕmec J
    Z Gesamte Inn Med; 1978 Nov; 33(21):797-8. PubMed ID: 735255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-independent cell-mediated alloimmunity detected by a microcytotoxicity assay.
    Gluckman JC; Sasportes M
    Transplantation; 1978 Jul; 26(1):70-2. PubMed ID: 675797
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural cytotoxicity and antibody-dependent cellular cytotoxicity of human lymphocytes depleted of HLA-DR bearing cells with monoclonal HLA-DR antibodies.
    Ng AK; Indiveri F; Pellegrino MA; Molinaro GA; Quaranta V; Ferrone S
    J Immunol; 1980 May; 124(5):2336-40. PubMed ID: 7365259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.